CHE at a glance
Chemed Corp (CHE, SEC CIK 19584) filed its latest 10-K annual report on February 27, 2026, a 10-Q quarterly report on July 31, 2026, an 8-K current report on July 28, 2026 and Form 4 insider filings as recently as October 1, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), Chemed Corp (CHE) reported revenue of $2.5 billion (up 4.1% from FY2024) and net income of $265.2 million. Diluted EPS was $18.34.
- As of June 30, 2026, 38 institutional investment managers tracked by SignalX reported holding Chemed Corp (CHE) shares worth $2.9 billion in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by MCNAMARA KEVIN J on September 28, 2026 of 2,000 shares at $513.45 per share.
- In the last 90 days, CHE insiders reported 0 open-market purchases ($0) and 6 open-market sales ($4.8M) on Form 4, a net sale of $4.8M.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $2.5B
- +4.1% vs prior year
- Insiders · 90 days
- 0 buys · 6 sells
- Net −$4.8M
- 13F holders
- 38 funds
- $2.9B · +0 vs prior quarter
- Latest 10-Q
- Jul 31, 2026
- Quarterly report
SignalX for CHE
Don't miss the next CHE filing
- Alerts as it files. A push when CHE files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut CHE, by share count.
- Ask anything. An AI agent that reads every CHE filing and answers with sources.
CHE alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| LEE SPENCER S | M | Sep 30, 2026 | 12,099 | $445.35 |
| LEE SPENCER S | M | Sep 30, 2026 | 12,099 | $445.35 |
| LEE SPENCER S | F | Sep 30, 2026 | 11,160 | $508.93 |
| HUTTON THOMAS C | M | Sep 28, 2026 | 4,629 | $445.35 |
| HUTTON THOMAS C | M | Sep 28, 2026 | 4,629 | $445.35 |
| HUTTON THOMAS C | F | Sep 28, 2026 | 4,270 | $506.65 |
| MCNAMARA KEVIN J | Sell | Sep 28, 2026 | 2,000 | $513.45 |
| MCNAMARA KEVIN J | Sell | Sep 18, 2026 | 2,000 | $501.40 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $2.4B | $2.5B |
| Operating Income | - | $366.5M | $338.2M |
| Net Income | $272.5M | $302.0M | $265.2M |
| Op. Margin | - | 15.1% | 13.4% |
| Net Margin | - | 12.4% | 10.5% |
| Balance Sheet | |||
| Total Assets | $1.7B | $1.7B | $1.5B |
| Equity | - | $1.1B | $979.4M |
| ROE | - | 27.0% | 27.1% |
| Per Share | |||
| EPS | $17.93 | $19.89 | $18.34 |
| Cash Flow | |||
| Operating CF | - | $417.5M | $388.3M |
| CapEx | $56.9M | $49.5M | $62.8M |
Source: XBRL data in Chemed Corp (CHE)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate CHE share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 38 | $2.90B |
| Q1 2026 | 38 | $2.30B |
| Q4 2025 | 35 | $2.58B |
| Q3 2025 | 36 | $2.91B |
| Q2 2025 | 35 | $2.92B |
| Q1 2025 | 35 | $2.85B |
| Q4 2024 | 30 | $2.17B |
| Q3 2024 | 27 | $1.09B |
- AQR Capital Management+556.9K (+134%)
- BlackRock+147.6K (+11%)
- Goldman Sachs Group+45.9K (+33%)
- Renaissance Technologies LLC+26.7K (+217%)
- Northern Trust+24.5K (+14%)
- Two Sigma Investments−279.3K (-93%)
- JPMorgan Chase & Co−97.6K (-19%)
- Millennium Management−54.2K (-52%)
- D.E. Shaw & Co−36.7K (-86%)
- Wells Fargo & Co−31.8K (-59%)
- Citadel Advisors LLC−114.1K
Source: 13F-HR filings on SEC EDGAR (aggregated from 274 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
CHE filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
8-K current reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Oct 1, 2026 | - | - | - |
| 4 | Sep 30, 2026 | - | - | - |
| 4 | Sep 29, 2026 | - | - | - |
| 4 | Sep 21, 2026 | - | - | - |
| 4 | Aug 24, 2026 | - | - | - |
| 4 | Aug 24, 2026 | - | - | - |
| 4 | Aug 10, 2026 | - | - | - |
| 4 | Aug 6, 2026 | - | - | - |
| 4 | Aug 4, 2026 | - | - | - |
| 4 | Aug 3, 2026 | - | - | - |
| 10-Q | Jul 31, 2026 | Jun 30, 2026 | - | |
| 8-K | Jul 28, 2026 | - | - | - |
| 4 | Jun 10, 2026 | - | - | |
| 4 | May 29, 2026 | - | - | |
| 8-K | May 19, 2026 | - | - | |
| 4 | May 8, 2026 | - | - | |
| 4 | May 4, 2026 | - | - | - |
| 10-Q | Apr 28, 2026 | Mar 31, 2026 | - | |
| 8-K | Apr 23, 2026 | - | - | - |
| 8-K | Apr 13, 2026 | - | - | - |
| 4 | Mar 30, 2026 | - | - | - |
| 4 | Mar 13, 2026 | - | - | - |
| 10-K | Feb 27, 2026 | Dec 31, 2025 | - | |
| 8-K | Feb 25, 2026 | - | Analysis | - |
| 4 | Feb 17, 2026 | - | - |
Related Health Care companies
- AHCO · AdaptHealth Corp.Services-Home Health Care Services
- ADUS · Addus HomeCare CorpServices-Home Health Care Services
- AVAH · Aveanna Healthcare Holdings, Inc.Services-Home Health Care Services
- BTSG · BrightSpring Health Services, Inc.Services-Home Health Care Services
- EHAB · Enhabit, Inc.Services-Home Health Care Services
- OPCH · Option Care Health, Inc.Services-Home Health Care Services
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
CHE SEC filings: frequently asked questions
Are CHE insiders buying or selling?
In the last 90 days, Chemed Corp (CHE) officers, directors and 10% owners reported no open-market purchases and 6 open-market sales worth $4.8 million by 3 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold CHE stock?
As of June 30, 2026, the largest Chemed Corp (CHE) holders among the 13F filers tracked by SignalX were BlackRock ($691.3 million), AQR Capital Management ($446.2 million), Vanguard Portfolio Management LLC ($366.6 million), Vanguard Capital Management LLC ($281.5 million), State Street Corp ($207.1 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was CHE's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), Chemed Corp (CHE) reported revenue of $2.5 billion (up 4.1% from FY2024) and net income of $265.2 million. Diluted EPS was $18.34. The figures come from the XBRL data in the 10-K.
What are the latest CHE SEC filings?
Chemed Corp (CHE) filed its latest 10-K annual report on February 27, 2026, a 10-Q quarterly report on July 31, 2026, an 8-K current report on July 28, 2026 and a Form 4 insider filing on October 1, 2026.
What is CHE's SEC CIK number?
Chemed Corp (CHE)'s SEC Central Index Key (CIK) is 19584. EDGAR lists every CHE filing under that number.
Ask anything about CHE
The research agent reads CHE's filings, financials, insider trades and 13F holders, then answers with sources.